A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.
about
Role of malignant ascites on human mesothelial cells and their gene expression profilesThe prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer.Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients.Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2.Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancerConstitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Gα(12).Targeted ovarian cancer treatment: the TRAILs of resistance.Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancersInsights into the pharmacological relevance of lysophospholipid receptors.A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.Absence of constitutive EGF receptor activation in ovarian cancer cell lines.Profiling of cytokines in human epithelial ovarian cancer ascites.Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosisClinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancerLPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer CellsFluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activityDirect Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells.Lysophospholipids activate ovarian and breast cancer cells.Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity.
P2860
Q33559857-5577BA05-69A4-442C-AA5A-5D5DD239290BQ33650479-6B0069A7-EC00-4F11-9397-ED1556F318DBQ33914512-4C050B79-8A10-45A3-8031-033F4780F0B0Q34260479-831067D3-9277-4DC5-A874-CD2F2388F7FDQ34291387-95D7BA50-E5E9-41FA-BB8D-A8BDC857553FQ34335443-828C993B-0CC3-474E-8366-04364EC19FBAQ34357465-D3EF47EB-88E1-49AD-85F2-C4DFA8EA2C21Q34517736-A977FBAE-3AC0-4268-81E0-92B54C4575F7Q34568531-744DB43C-6AA8-4E12-A51F-478E103EADDFQ35180349-AED44BC4-DCDF-42E3-8D55-28E21D50748CQ35609438-FC2BDB0F-BC3E-440A-8616-6CB4BDBED043Q35677625-EA54F776-E780-48EC-B125-F59FA7F5EE27Q35853199-34B489D3-CB6E-4B58-9446-417C69B4CB20Q35982568-F994FF29-870A-4AE3-8FCB-535D6348E3BAQ36135788-E50473F4-12E4-42B7-A744-C07F4E5BC6BFQ36206483-78168596-4184-4494-B991-F1BB1D55076BQ36358324-56281C1E-900F-4740-8B9A-F925105BA15BQ36478459-88C75D6D-6C2F-4A44-9D40-C19F2508303EQ36616823-2BC9BA0D-2508-454E-8D35-B4DCF96655D9Q36664973-4AA440AC-5D08-4C06-B409-52E83EBCAB23Q36861053-5683F350-4E1E-4322-9153-13A14BAECBC3Q37022535-BB6A2B6D-2F04-4627-8B63-BDBEA51F781FQ37196532-36B6DD82-BB59-4E1B-BCEE-F4F6FAEBF877Q41658465-FECB893F-C028-4E38-802B-F1FB8423B9CFQ42821442-48D5BC48-A20F-4952-99D3-1A48B74686FEQ49724715-EAF3CEA4-79B7-481A-A710-63A5D846BFE5Q55438393-18E44C38-3ECE-4D08-9E1A-57F304BE9F7E
P2860
A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
A putative new growth factor i ...... tion, and mechanism of action.
@en
A putative new growth factor i ...... tion, and mechanism of action.
@nl
type
label
A putative new growth factor i ...... tion, and mechanism of action.
@en
A putative new growth factor i ...... tion, and mechanism of action.
@nl
prefLabel
A putative new growth factor i ...... tion, and mechanism of action.
@en
A putative new growth factor i ...... tion, and mechanism of action.
@nl
P2093
P1433
P1476
A putative new growth factor i ...... tion, and mechanism of action.
@en
P2093
P304
P407
P577
1988-03-01T00:00:00Z